Development and Validation of HPTLC Method for Estimation of Safinamide Mesylate in Bulk and in Tablet Dosage Form

Table 1

Analysis of Tablet formulation (Label claim: 50 mg per tablet).

Concentration; (ng μL^−1)	Amount found (ng)	Amount found (%)	% R.S.D.
1000	1008.8	100.8
	999.76	99.97
	995.63	99.56
	1006.7	100.6
	1011.3	101.1
	994.14	99.41
Mean ± S.D.	1002.7±7.22	100.2±0.72	0.72